Leading Chinese medical devices maker Mindray Medical International Limited (MR) has announced that it will feature its new products at the China International Medical Equipment Fair (“CMEF”), slated to be held in Shenyang from October 12 -15, 2010. CMEF is the largest exhibition of medical equipment in the Asia-Pacific region.
Mindray plans to showcase more than 50 models from its three major product segments at the CMEF. The company will also exhibit a new magnetic resonance imaging (MRI) equipment, dubbed Magsense 360, planned for launch within the next few quarters.
Mindray reckons the CMEF as the ideal platform to demonstrate its expanding portfolio of high-quality products and its sustained R&D commitment to provide clinicians with the latest technology that enhances patient care. The company targets to launch seven to nine new products in 2010.
Mindray recently launched its latest M7 ultrasound system in the U.S. market. This novel system leverages the company’s high-performance “System On Chip (SOC)” technology to bring a high level of imaging capability to a portable system. The company believes that the M7 system provides good value to the customers by combining economy and differentiating attributes.
With its operational headquarters in Shenzhen, China, Mindray is a global Chinese medical devices company. It operates through three segments: Patient Monitoring and Life Support Products, In-Vitro Diagnostic Products and Medical Imaging Systems. Besides China, the company operates in North America, Europe and other Asian countries.
Mindray has a strong position in the low and mid segments of the medical devices market in China and is poised to benefit from the solid fundamentals of the Chinese healthcare sector. Its new product development initiatives, expanding international footprint (and revenues) and solid sales infrastructure remain encouraging. Mindray is also well positioned to benefit from the healthcare reform in China. However, the company is exposed to intense competition-driven pricing pressure.
MINDRAY MEDICAL (MR): Free Stock Analysis Report
Zacks Investment Research
